RSG-24342-76377

3 vaccinations 1 coded response 3 check-ins 1 free-text entry 0 call cases

Sex: Male
Age at first dose: 41-45
ZIP prefix: 191 / PA
Registered: 2021-10-09

Relationship: Self
Race: Black or African American
Ethnicity: Not Hispanic or Latino

Registered dependents

ZQT-14051-39209 Adult relative or friend · Female · 2021-10-09

3L5-51497-87170 Child or adolescent in my care · Male · 2021-10-09

GBC-10955-85973 Child or adolescent in my care · Male · 2021-10-09

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-22
Dose 1 — Pfizer-BioNTech
2021-04-12
Dose 2 — Pfizer-BioNTech
2021-10-09
Registered in v-safe
2021-10-11
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-10-25
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2022-04-12
Survey response — 12 months, dose 2
MedDRA: Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair

Free text: Sure throat and some congestion.

MedDRA releases: 2024-11 · check-in free text available
2022-10-25
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-22	Pfizer-BioNTech	No
2	2021-04-12	Pfizer-BioNTech	No
3	2021-10-25	Pfizer-BioNTech	Flu

Free text

Release 11 — 12 months, dose 2

2022-04-12

Symptoms: Sure throat and some congestion.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Oropharyngeal pain	·	·	✓
SD	Respiratory tract congestion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release